RIVM_Logo_Engels

Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment

 

Home / Documents and publications / Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment

RIVM Committed to health and sustainability
Menu